July 1, 2015
Aeras and IDT Announce Partnership
Aeras and IDT Biologika annouced a strategic partnership that includes the acquisition of Aeras Biopharmaceutical Development Center’s (BDC) manufacturing facility by IDT.
Aeras is a non-profit biotech organization, located in Rockville, working to develop new tuberculosis vaccines that are affordable and accessible to all who need them. IDT Biologika is a privately-held company with more than 90 years of experience researching, developing, manufacturing and marketing biologics for the global protection of human and animal health.
The new strategic partnership allows each organization to focus on its core strengths: Aeras with its resources on TB vaccine development and IDT on growing a new commercial entity for vaccine development manufacturing.
IDT and Aeras will jointly share occupancy of the current Aeras location in Rockville, Maryland. Within the partnership Aeras will work closely with IDT on process development and manufacturing activities to our U.S. market offering.
To learn more about the Aeras and IDT Biologika’s partnership, click on the press release.